Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Neuropathologica
Published in: Acta Neuropathologica 4/2017

Open Access 01-04-2017 | Original Paper

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica

Authors: Yong Guo, Stephen D. Weigand, Bogdan F. Popescu, Vanda A. Lennon, Joseph E. Parisi, Sean J. Pittock, Natalie E. Parks, Stacey L. Clardy, Charles L. Howe, Claudia F. Lucchinetti

Published in: Acta Neuropathologica | Issue 4/2017

Login to get access

Abstract

Pathogenic autoantibodies associated with neuromyelitis optica (NMO) induce disease by targeting aquaporin-4 (AQP4) water channels enriched on astrocytic endfeet at blood–brain interfaces. AQP4 is also expressed at cerebrospinal fluid (CSF)–brain interfaces, such as the pial glia limitans and the ependyma and at the choroid plexus blood–CSF barrier. However, little is known regarding pathology at these sites in NMO. Therefore, we evaluated AQP4 expression, microglial reactivity, and complement deposition at pial and ependymal surfaces and in the fourth ventricle choroid plexus in 23 autopsy cases with clinically and/or pathologically confirmed NMO or NMO spectrum disorder. These findings were compared to five cases with multiple sclerosis, five cases of choroid plexus papilloma, and five control cases without central nervous system disease. In the NMO cases, AQP4 immunoreactivity was reduced relative to control levels in the pia (91%; 21/23), ependyma (56%; 9/16), and choroid plexus epithelium (100%; 12/12). AQP4 immunoreactivity was normal in MS cases in these regions. Compared to MS, NMO cases also showed a focal pattern of pial and ependymal complement deposition and more pronounced microglial reactivity. In addition, AQP4 loss, microglial reactivity, and complement deposition colocalized along the pia and ependyma only in NMO cases. Within the choroid plexus, AQP4 loss was coincident with C9neo immunoreactivity on epithelial cell membranes only in NMO cases. These observations demonstrate that NMO immunopathology extends beyond perivascular astrocytic foot processes to include the pia, ependyma, and choroid plexus, suggesting that NMO IgG-induced pathological alterations at CSF–brain and blood–CSF interfaces may contribute to the occurrence of ventriculitis, leptomeningitis, and hydrocephalus observed among NMO patients. Moreover, disruption of the blood–CSF barrier induced by binding of NMO IgG to AQP4 on the basolateral surface of choroid plexus epithelial cells may provide a unique portal for entry of the pathogenic antibody into the central nervous system.
Appendix
Available only for authorised users
Literature
1.
Amiry-Moghaddam M, Ottersen OP (2003) The molecular basis of water transport in the brain. Nat Rev Neurosci 4:991–1001CrossRefPubMed
2.
Banker P, Sonni S, Kister I, Loh JP, Lui YW (2012) Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders. Mult Scler 18:1050–1053CrossRefPubMed
3.
Boyer RS, Sun NC, Verity A, Nies KM, Louie JS (1980) Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus. J Rheumatol 7:645–650PubMed
4.
Brentjens J, Ossi E, Albini B, Sepulveda M, Kano K, Sheffer J, Vasilion P, Marine E, Baliah T, Jockin H et al (1977) Disseminated immune deposits in lupus erythematosus. Arthritis Rheum 20:962–968CrossRefPubMed
5.
Canova C, Neal JW, Gasque P (2006) Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis. J Neuroinflammation 3:22CrossRefPubMedPubMedCentral
6.
Clardy SL, Lucchinetti CF, Krecke KN, Lennon VA, O’Toole O, Weinshenker BG, Boyd CD, Krieger S, McGraw C, Guo Y et al (2014) Hydrocephalus in neuromyelitis optica. Neurology 82:1841–1843CrossRefPubMedPubMedCentral
7.
Dahlback K, Lofberg H, Dahlback B (1989) Vitronectin colocalizes with Ig deposits and C9 neoantigen in discoid lupus erythematosus and dermatitis herpetiformis, but not in bullous pemphigoid. Br J Dermatol 120:725–733CrossRefPubMed
8.
Damkier HH, Brown PD, Praetorius J (2013) Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev 93:1847–1892CrossRefPubMed
9.
Davis JA, Weisman MH, Dail DH (1978) Vascular disease in infective endocarditis. Report of immune-mediated events in skin and brain. Arch Intern Med 138:480–483CrossRefPubMed
10.
Derouiche A, Pannicke T, Haseleu J, Blaess S, Grosche J, Reichenbach A (2012) Beyond polarity: functional membrane domains in astrocytes and Muller cells. Neurochem Res 37:2513–2523CrossRefPubMed
11.
Dujmovic I, Mader S, Schanda K, Deisenhammer F, Stojsavljevic N, Kostic J, Berger T, Drulovic J, Reindl M (2011) Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders. J Neuroimmunol 234:124–130CrossRefPubMed
12.
Eichel R, Meiner Z, Abramsky O, Gotkine M (2008) Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates. Arch Neurol 65:267–271CrossRefPubMed
13.
Falangola MF, Castro-Filho BG, Petito CK (1994) Immune complex deposition in the choroid plexus of patients with acquired immunodeficiency syndrome. Ann Neurol 36:437–440CrossRefPubMed
14.
Feng X, Papadopoulos MC, Liu J, Li L, Zhang D, Zhang H, Verkman AS, Ma T (2009) Sporadic obstructive hydrocephalus in Aqp4 null mice. J Neurosci Res 87:1150–1155CrossRefPubMedPubMedCentral
15.
Finn R, Evans CC, Lee L (2014) Strain-dependent brain defects in mouse models of primary ciliary dyskinesia with mutations in Pcdp1 and Spef2. Neuroscience 277:552–567CrossRefPubMedPubMedCentral
16.
Fukui MB, Williams RL, Mudigonda S (2001) CT and MR imaging features of pyogenic ventriculitis. AJNR Am J Neuroradiol 22:1510–1516PubMed
17.
Gershwin ME, Hyman LR, Steinberg AD (1975) The choroid plexus in CNS involvement of systemic lupus erythematosus. J Pediatr 87:588–590CrossRefPubMed
18.
Getsios S, Huen AC, Green KJ (2004) Working out the strength and flexibility of desmosomes. Nat Rev Mol Cell Biol 5:271–281CrossRefPubMed
19.
Guo Y, Lennon VA, Popescu BF, Grouse CK, Topel J, Milone M, Lassmann H, Parisi JE, Pittock SJ, Stefoski D et al (2014) Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol 71:1025–1029CrossRefPubMed
20.
Hinson SR, Romero MF, Popescu BF, Lucchinetti CF, Fryer JP, Wolburg H, Fallier-Becker P, Noell S, Lennon VA (2012) Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc Natl Acad Sci USA 109:1245–1250CrossRefPubMed
21.
Hintner H, Sepp N, Dahlback K, Dahlback B, Fritsch P, Breathnach SM (1990) Deposition of C3, C9 neoantigen and vitronectin (S-protein of complement) in lichen planus pemphigoides. Br J Dermatol 123:39–47CrossRefPubMed
22.
Hoffman WH, Casanova MF, Cudrici CD, Zakranskaia E, Venugopalan R, Nag S, Oglesbee MJ, Rus H (2007) Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. Exp Mol Pathol 83:65–72CrossRefPubMedPubMedCentral
23.
Howe CL, Kaptzan T, Magana SM, Ayers-Ringler JR, LaFrance-Corey RG, Lucchinetti CF (2014) Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures. Glia 62:692–708CrossRefPubMed
24.
Ibanez-Tallon I, Pagenstecher A, Fliegauf M, Olbrich H, Kispert A, Ketelsen UP, North A, Heintz N, Omran H (2004) Dysfunction of axonemal dynein heavy chain Mdnah5 inhibits ependymal flow and reveals a novel mechanism for hydrocephalus formation. Hum Mol Genet 13:2133–2141CrossRefPubMed
25.
Iorio R, Monforte M, Pierconti F, Iodice F, Sabatelli M (2014) Tuberculous nephritis accompanying neuromyelitis optica: causal or coincidental association? J Neurol 261:1028–1030CrossRefPubMed
26.
Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP et al (2010) Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 7:52CrossRefPubMedPubMedCentral
27.
Jeantroux J, Kremer S, Lin XZ, Collongues N, Chanson JB, Bourre B, Fleury M, Blanc F, Dietemann JL, de Seze J (2012) Diffusion tensor imaging of normal-appearing white matter in neuromyelitis optica. J Neuroradiol 39:295–300CrossRefPubMed
28.
Johanson CE, Stopa EG, McMillan PN (2011) The blood-cerebrospinal fluid barrier: structure and functional significance. Methods Mol Biol 686:101–131CrossRefPubMed
29.
Kamran S, Bener AB, Alper D, Bakshi R (2004) Role of fluid-attenuated inversion recovery in the diagnosis of meningitis: comparison with contrast-enhanced magnetic resonance imaging. J Comput Assist Tomogr 28:68–72CrossRefPubMed
30.
Kim SH, Kim W, Huh SY, Lee KY, Jung IJ, Kim HJ (2013) Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels. J Clin Neurol 9:36–42CrossRefPubMedPubMedCentral
31.
Kim SM, Waters P, Vincent A, Go MJ, Park KS, Sung JJ, Lee KW (2011) Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica. J Neurol 258:2176–2180CrossRefPubMed
32.
Lee L (2013) Riding the wave of ependymal cilia: genetic susceptibility to hydrocephalus in primary ciliary dyskinesia. J Neurosci Res 91:1117–1132CrossRefPubMed
33.
Lee L, Campagna DR, Pinkus JL, Mulhern H, Wyatt TA, Sisson JH, Pavlik JA, Pinkus GS, Fleming MD (2008) Primary ciliary dyskinesia in mice lacking the novel ciliary protein Pcdp1. Mol Cell Biol 28:949–957CrossRefPubMed
34.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473–477CrossRefPubMedPubMedCentral
35.
Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112CrossRefPubMed
36.
Li Z, Terada N, Ohno N, Ohno S (2005) Immunohistochemical analyses on albumin and immunoglobulin in acute hypertensive mouse kidneys by “in vivo cryotechnique”. Histol Histopathol 20:807–816PubMed
37.
38.
Llufriu S, Castillo J, Blanco Y, Ramio-Torrenta L, Rio J, Valles M, Lozano M, Castella MD, Calabia J, Horga A et al (2009) Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months. Neurology 73:949–953CrossRefPubMed
39.
Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T (2014) The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 24:83–97CrossRefPubMedPubMedCentral
40.
Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE et al (2002) A role for humoral mechanisms in the pathogenesis of Devic’s neuromyelitis optica. Brain 125:1450–1461CrossRefPubMed
41.
Magana SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J et al (2011) Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol 68:870–878CrossRefPubMedPubMedCentral
42.
Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Weinshenker BG (2009) Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 72:712–717CrossRefPubMed
43.
Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ (2016) Clinical utility of testing AQP4-IgG in CSF: guidance for physicians. Neurol Neuroimmunol Neuroinflamm 3:e231CrossRefPubMedPubMedCentral
44.
Marchiando AM, Graham WV, Turner JR (2010) Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5:119–144CrossRefPubMed
45.
Matsuo M, Shimada A, Koshida S, Saga Y, Takeda H (2013) The establishment of rotational polarity in the airway and ependymal cilia: analysis with a novel cilium motility mutant mouse. Am J Physiol Lung Cell Mol Physiol 304:L736–L745CrossRefPubMed
46.
McIntosh RM, Copack P, Chernack WB, Griswold WR, Weil R 3rd, Koss MN (1975) The human choroid plexus and autoimmune nephritis. Arch Pathol 99:48–50PubMed
47.
Melhem ER, Jara H, Eustace S (1997) Fluid-attenuated inversion recovery MR imaging: identification of protein concentration thresholds for CSF hyperintensity. AJR Am J Roentgenol 169:859–862CrossRefPubMed
48.
Moore GR, Laule C, Leung E, Pavlova V, Morgan BP, Esiri MM (2016) Complement and humoral adaptive immunity in the human choroid plexus: roles for stromal concretions, basement membranes, and epithelium. J Neuropathol Exp Neurol 75:415–428CrossRefPubMedPubMedCentral
49.
Mottaghi P, Ashtari F, Karimzadeh H, Seidbonakdar Z, Karimifar M, Salesi M (2009) Devic’s syndrome concomitant with nephritis in a young woman. Clin Rheumatol 28:1239–1240CrossRefPubMed
50.
Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME (2001) Syntrophin-dependent expression and localization of aquaporin-4 water channel protein. Proc Natl Acad Sci USA 98:14108–14113CrossRefPubMedPubMedCentral
51.
Oliver C, Gonzalez CA, Alvial G, Flores CA, Rodriguez EM, Batiz LF (2013) Disruption of CDH2/N-cadherin-based adherens junctions leads to apoptosis of ependymal cells and denudation of brain ventricular walls. J Neuropathol Exp Neurol 72:846–860CrossRefPubMed
52.
Olsson JE, Link H (1973) Distribution of serum proteins and beta-trace protein within the nervous system. J Neurochem 20:837–846CrossRefPubMed
53.
54.
Pittella JE, Bambirra EA (1989) Histopathological and immunofluorescence study of the choroid plexus in hepatosplenic schistosomiasis mansoni. Am J Trop Med Hyg 41:548–552PubMed
55.
Pittella JE, Bambirra EA (1991) Immune complexes in the choroid plexus in liver cirrhosis. Arch Pathol Lab Med 115:220–222PubMed
56.
57.
Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O’Toole O, Wingerchuk DM (2013) Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol 12:554–562CrossRefPubMed
58.
Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA (2006) Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 63:964–968CrossRefPubMed
59.
Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, Newell K, Mandler RN, Pittock SJ, Weinshenker BG et al (2011) Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 76:1229–1237CrossRefPubMedPubMedCentral
60.
Rappaport ZH, Shalit MN (1989) Perioperative external ventricular drainage in obstructive hydrocephalus secondary to infratentorial brain tumours. Acta Neurochir (Wien) 96:118–121CrossRef
61.
Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM et al (2007) Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130:1194–1205CrossRefPubMed
62.
Saadoun S, Papadopoulos MC (2010) Aquaporin-4 in brain and spinal cord oedema. Neuroscience 168:1036–1046CrossRefPubMed
63.
Saadoun S, Papadopoulos MC (2015) Role of membrane complement regulators in neuromyelitis optica. Mult Scler 21:1644–1654CrossRefPubMed
64.
Saiki S, Ueno Y, Moritani T, Sato T, Sekine T, Kawajiri S, Adachi S, Yokoyama K, Tomizawa Y, Motoi Y et al (2009) Extensive hemispheric lesions with radiological evidence of blood–brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci 284:217–219CrossRefPubMed
65.
Saji E, Arakawa M, Yanagawa K, Toyoshima Y, Yokoseki A, Okamoto K, Otsuki M, Akazawa K, Kakita A, Takahashi H et al (2013) Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 73:65–76CrossRefPubMed
66.
Serot JM, Bene MC, Faure GC (1994) Comparative immunohistochemical characteristics of human choroid plexus in vascular and Alzheimer’s dementia. Hum Pathol 25:1185–1190CrossRefPubMed
67.
Sher JH, Pertschuk LP (1974) Immunoglobulin G deposits in the choroid plexus of a child with systemic lupus erythematosus. J Pediatr 85:385–387CrossRefPubMed
68.
Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P (1999) Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest 79:1247–1259PubMed
69.
70.
71.
Stokum JA, Kurland DB, Gerzanich V, Simard JM (2015) Mechanisms of astrocyte-mediated cerebral edema. Neurochem Res 40:317–328CrossRefPubMed
72.
Terris J, Ecelbarger CA, Marples D, Knepper MA, Nielsen S (1995) Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 269:F775–F785PubMed
73.
Tham DK, Moukhles H (2011) Regulation of Kir4.1 and AQP4 expression and stability at the basolateral domain of epithelial MDCK cells by the extracellular matrix. Am J Physiol Renal Physiol 301:F396–F409CrossRefPubMedPubMedCentral
74.
75.
Vella J, Zammit C, Di Giovanni G, Muscat R, Valentino M (2015) The central role of aquaporins in the pathophysiology of ischemic stroke. Front Cell Neurosci 9:108CrossRefPubMedPubMedCentral
76.
Verkman AS, Phuan PW, Asavapanumas N, Tradtrantip L (2013) Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol 23:684–695CrossRefPubMedPubMedCentral
77.
Walker-Caulfield ME, Guo Y, Johnson RK, McCarthy CB, Fitz-Gibbon PD, Lucchinetti CF, Howe CL (2015) NFkappaB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG. J Neuroinflammation 12:185CrossRefPubMedPubMedCentral
78.
Whish S, Dziegielewska KM, Mollgard K, Noor NM, Liddelow SA, Habgood MD, Richardson SJ, Saunders NR (2015) The inner CSF-brain barrier: developmentally controlled access to the brain via intercellular junctions. Front Neurosci 9:16CrossRefPubMedPubMedCentral
79.
Wilson GR, Wang HX, Egan GF, Robinson PJ, Delatycki MB, O’Bryan MK, Lockhart PJ (2010) Deletion of the Parkin co-regulated gene causes defects in ependymal ciliary motility and hydrocephalus in the quakingviable mutant mouse. Hum Mol Genet 19:1593–1602CrossRefPubMed
80.
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815CrossRefPubMed
81.
82.
Zaffaroni M, Italian Devic’s Study G (2004) Cerebrospinal fluid findings in Devic’s neuromyelitis optica. Neurol Sci 25(Suppl 4):S368–S370CrossRef
Metadata
Title
Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
Authors
Yong Guo
Stephen D. Weigand
Bogdan F. Popescu
Vanda A. Lennon
Joseph E. Parisi
Sean J. Pittock
Natalie E. Parks
Stacey L. Clardy
Charles L. Howe
Claudia F. Lucchinetti
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Acta Neuropathologica / Issue 4/2017
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-017-1682-1

Other articles of this Issue 4/2017

Acta Neuropathologica 4/2017 Go to the issue

Original Paper

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease

Original Paper

Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo

Original Paper

UK Iatrogenic Creutzfeldt–Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches

Correspondence

Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome

Original Paper

Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis

Original Paper

Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels